Nuvation Bio NUVB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.4M+115% | -$36.59M+34.4% | -$55.79M+5.4% | -$59.01M-10.8% | -$53.24M-7.7% | ||
| $536K-0.6% | $539K+0.9% | $534K+50.0% | $356K+14.8% | $310K+41.6% | ||
| $9.03M+13.1% | $7.99M-0.4% | $8.02M-33.3% | $12.03M+53.2% | $7.85M-22.9% | ||
| $321K+273% | $86K-59.6% | $213K+1,836% | $11K— | $0— | ||
| $6.65M-14.3% | $7.75M— | —— | —— | -$12.31M-198% | ||
| $12.96M— | —— | —— | $11.88M+184% | $4.19M+169% | ||
| -$12.32M-198% | $12.6M— | —— | —— | -$8.94M-222% | ||
| -$3.78M-2,709% | $145K-82.9% | $846K— | $0+100% | -$145K-102% | ||
| $4.44M+70.0% | $2.61M+290% | $669K— | $0-100% | $1.14M— | ||
| $5.07M+117% | -$29.73M+43.8% | -$52.89M-9.8% | -$48.18M-13.0% | -$42.63M+7.9% | ||
| $48K— | $0-100% | $7.75M+4,180% | $181K+151% | $72K— | ||
| -$43.64M-150% | $87.08M— | —— | $54.88M+1.3% | $54.18M+4.7% | ||
| $908K-88.2% | $7.71M+1,282% | $558K-26.8% | $762K-29.6% | $1.08M+28.8% | ||
| $0-100% | $11.2M— | $0-100% | $166K-68.9% | $534K-93.0% | ||
| $44K-99.5% | $8.06M+1,509% | $501K-99.7% | $193.42M+35,196% | $548K— | ||
| -$172K+23.2% | -$224K-250% | -$64K+50.0% | -$128K-185% | $151K-86.5% | ||
| -$38.7M-159% | $65.19M— | —— | $199.99M+1,532% | $12.25M— | ||
| —— | $720.5K0.0% | $720.5K0.0% | $720.5K0.0% | $720.5K+745% | ||
| —— | $49.25K0.0% | $49.25K0.0% | $49.25K0.0% | $49.25K-47.2% | ||
| $321K+273% | $86K-59.6% | $213K+1,836% | $11K— | $0— | ||
| $21K-96.9% | $670K+219% | $210K-53.6% | $453K+283% | -$248K— | ||
| $426K— | —— | $4.33M+97.0% | $2.2M-4.6% | $2.31M+140% | ||
| -$24K+98.9% | -$2.24M-245% | $1.54M+244% | -$1.07M-172% | $1.48M+361% | ||
| $4.43M-22.2% | $5.7M+10.5% | $5.16M+859% | $538K+3,743% | $14K— | ||
| $4.44M+70.0% | $2.61M+290% | $669K— | $0-100% | $1.14M— | ||
| -$5.08M-1.2% | -$5.02M-3.3% | -$4.86M-1,725% | -$266K— | $0— | ||
| -$66K— | —— | —— | $171K+4.3% | $164K+360% | ||
| $48K-46.1% | $89K+642% | $12K-93.4% | $181K+151% | $72K— | ||
| $864K— | —— | —— | -$150M— | $0— | ||
| -$2.87M-354% | $1.13M+284% | -$612K-34.8% | -$454K-160% | $751K-34.4% | ||
| $109K— | —— | $99K+13.8% | $87K-97.6% | $3.69M+805% | ||
| —— | $967.75K0.0% | $967.75K0.0% | $967.75K0.0% | $967.75K+524% | ||
| $5.02M+117% | -$29.73M+51.0% | -$60.64M-25.4% | -$48.36M-13.3% | -$42.7M+7.8% | ||
| $5.02M+117% | -$29.73M+51.0% | -$60.64M-25.4% | -$48.36M-13.3% | -$42.7M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.